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Abstract
Background: Antenatal depressive symptoms affect around 12.3% of women in in low and middle income
countries (LMICs) and data are accumulating about associations with adverse outcomes for mother and child.
Studies from rural, low-income country community samples are limited. This paper aims to investigate whether
antenatal depressive symptoms predict perinatal complications in a rural Ethiopia setting.
Methods: A population-based prospective study was conducted in Sodo district, southern Ethiopia. A total of 1240
women recruited in the second and third trimesters of pregnancy were followed up until 4 to 12 weeks
postpartum. Antenatal depressive symptoms were assessed using a locally validated version of the Patient Health
Questionnaire (PHQ-9) that at a cut-off score of five or more indicates probable depression. Self-report of perinatal
complications, categorised as maternal and neonatal were collected by using structured interviewer administered
questionnaires at a median of eight weeks post-partum. Multivariate analysis was conducted to examine the
association between antenatal depressive symptoms and self-reported perinatal complications.
Result: A total of 28.7% of women had antenatal depressive symptoms (PHQ-9 score ≥ 5). Women with antenatal
depressive symptoms had more than twice the odds of self-reported complications in pregnancy (OR=2.44, 95% CI:
1.84, 3.23), labour (OR= 1.84 95% CI: 1.34, 2.53) and the postpartum period (OR=1.70, 95% CI: 1.23, 2.35) compared
to women without these symptoms. There was no association between antenatal depressive symptoms and
pregnancy loss or neonatal death.
Conclusion: Antenatal depressive symptoms are associated prospectively with self-reports of perinatal
complications. Further research is necessary to further confirm these findings in a rural and poor context using
objective measures of complications and investigating whether early detection and treatment of depressive
symptoms reduces these complications.
Keywords: Antenatal depressive symptoms, Perinatal complications, Prospective study, Rural and low income,
Ethiopia
Background
Antenatal depression affects about 10% of women in
High Income Countries (HICs) [1, 2], in Low and
Middle Income Counties (LMICs) is higher, with some
variation across studies. In these settings, the prevalence
varies from 5% to nearly 40% [3–7] with a meta-analysis
in 2004 of 17 studies from LMICs reporting a prevalence
of 15.5% [2].
Antenatal depression is associated with increased
functional impairment [8, 9], reduced self-care [10–12]
and increased somatic complaints [9, 13, 14], which rise
the risk of perinatal complications. Studies in HICs have
reported association of antenatal depression with pre-
eclampsia [15, 16], pregnancy and labor complications
[17], premature contraction, increased use of analgesics
and increased nausea during pregnancy [18]. Few studies
from LMICs reported that antenatal depression was
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associated with increased risk of prolonged labor [19, 20],
preeclampsia [20, 21] and increased risk of prolonged
pregnancy [20].
There is accumulating evidence of adverse impacts of
antenatal depression on the newborn [22, 23]. Low birth
weight has been associated with antenatal depression in
some [23, 24], but not all [19, 25], studies. No association
between antenatal depression and neonatal mortality has
been observed [20], but depression prior to pregnancy was
associated with increased odds of stillbirth [26].
Most studies investigating the association between ante-
natal depression and perinatal complications were conducted
in high income countries. Evidence about the impact on
perinatal complications from rural community samples in
LMICs is limited despite the high prevalence of both ante-
natal depression [5, 7] and perinatal complications [27–29]
in such settings. Previous studies were limited by not con-
trolling adequately for potential confounders, such as past
history of adverse perinatal outcomes and chronic illnesses.
In our baseline study from a rural Ethiopian commu-
nity, antenatal depressive symptoms were associated
with increased non-scheduled antenatal care visits and
pregnancy-related emergency visits [30], which indicates
the possibility of an association of antenatal depressive
symptoms with perinatal complications. The current
study, therefore, aimed to investigate the effect of ante-
natal depressive symptoms on self-reported perinatal
complications in rural Ethiopian women.
Methods
Study Design and setting
A population-based prospective study was conducted in
Sodo district, southern Ethiopia, located approximately
100km from the capital city Addis Ababa. The district
has a population of about 160,000 people and is divided
into 58 sub-districts (‘kebeles’), four urban and 54 rural.
Agriculture is the main source of income and the official
language in the district is Amharic.
There are eight health centres (primary healthcare
facilities) in the district and a health post for every sub-
district. The health post is frontline primary healthcare
facility staffed by community-based healthcare workers,
Health Extension Workers (HEWs). HEWs are respon-
sible for performing health prevention and promotion
activities, to identify and monitor pregnant mothers and
to maintain up-to-date maternal records in health posts.
Members of health development army, a community-
based network of health education volunteers each of
whom covers five families, are also required to report
pregnant women in their respective units to HEWs.
Cohort Recruitment
The cohort was established by recruiting all consenting
eligible pregnant women. These were women in their
second and third trimesters of pregnancy, permanently
residing in the study area at least for the preceding six
months and without any cognitive and or hearing im-
pairment that impaired adequate communication.
A network of community based healthcare workers
(Health Extension Workers, HEWs), community based-
healthcare education volunteers, and kebele chairmen
and pregnant women themselves acted as key infor-
mants to identify all antenatal women in their respective
sub-districts. The data collectors then conducted inter-
view through home to home visits of identified women
after informed consent had been obtained. Data collec-
tors would declare potential participants “untraceable”
after three recruiting visits had been unsuccessful.
A total of 1,355 women were identified within a three-
month period, between early September and end of
December, 2014. Of these, 44 identified antenatal women
were in the first trimester of pregnancy and so were non-
eligible [30]. Thus, a total of 1311 women were eligible
and invited to participate. All eligible participants were
prospectively followed up until 4-12 weeks (a median of
eight weeks) after delivery. Four weeks was considered as
an optimal time point to distinguish postpartum depres-
sion from postpartum blues as defined in DSM IV [31]
and to reduce chance of recall bias.
Sample size
The aforementioned sample size was estimated using
EpiInfo version 7 [32] which was used to estimate the
sample size for another paper [30] assuming statistical
power of 80% and a 95% confidence interval. For this, a
19.9% prevalence of antenatal depressive symptoms [33]
and a 34% antenatal care utilisation [34] as an outcome
variable were used, assuming a 10% difference between
women with and without antenatal depression.
Data quality control and reporting
Forty experienced data collectors along with four supervi-
sors conducted the data collection process after two days
of training. All the data collectors were recruited from the
local community and they had a minimum educational
level of Grade 10. Most of them had either certificate or
Diploma in relevant fields such as community healthcare.
Among the supervisors, one had a Bachelor degree and
the remaining had Diplomas in various related disciplines.
The training was aimed to reduce respondent bias like so-
cial desirability bias by helping trainees understand the
contents of the questionnaire, objectives and ethical issues
relevant to the study. The data collection was closely
monitored by the coordinator of the study through weekly
meetings and regular telephone calls. Completed
questionnaires were first checked by the supervisors,
followed by the coordinator of the study and finally by the
data entry clerks for consistency and missing data.
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Questionnaires deemed to have missing or inconsistent
data were returned back to the data collectors for reinves-
tigation. Data were double entered using EpiData version
3.1 [32]. Data was reported in adherence to a checklist
from STROBE statement [35] to maintain standard of
reporting cohort data.
Measurement
Outcome variables
The outcome variables were self-reported perinatal com-
plications. The perinatal period is mostly defined as
extending from 22 weeks of gestation to seven days after
birth [36]. In this study, we used ‘perinatal complica-
tions’ to represent complications of the mother or the
neonate that occurred between two weeks prior to child-
birth and seven days after birth to reduce potential of re-
call bias. Perinatal complications were self-reported
since both maternal healthcare services and maternal
healthcare records in Ethiopia have major limitations
[34, 37–39] and women have been shown to be more
reliable source of such information [40].
Items adapted from the Ethiopian Demographic and
Health Survey [34] were used to collect the data about po-
tential perinatal complications. The instrument explored
symptoms indicative of pregnancy complications two
weeks prior to childbirth such as swollen hands/face,
blurred vision, severe abdominal pain, discharge with un-
usual odor, pain during urination, severe headache, severe
weakness. The following potential labour complications
were explored: severe bleeding, severe headache, convul-
sions, high fever, loss of consciousness, labor lasting more
than 12 hours, placenta not delivered within 30 minutes
of the baby, tear, and premature rupture of membranes.
Postpartum complications included: severe bleeding,
blurred vision, convulsions, swollen hands and or face,
high fever, malodorous vaginal discharge, loss of con-
sciousness, severe headache, pain during urination, severe
weakness, and difficulty of breathing and severe abdom-
inal pain. Finally, complications affecting the neonate in-
cluded: difficulty of breathing, yellow skin or eye color,
poor sucking, pus or bleeding around umbilical cord, skin
lesions or blisters, convulsions or rigidity, unconscious-
ness, red or swollen eyes with pus, any physical impair-
ment and any physician diagnosed illness.
Adverse perinatal outcomes, including stillbirth, spon-
taneous abortion and neonatal mortality, were also
assessed. Loss of pregnancy before 28 weeks of gestation
was defined as “spontaneous abortion” and after 28
weeks “stillbirth” [41, 42]. Death of any live birth within
28 days was defined as “neonatal mortality”.
Primary exposure
For antenatal depressive symptoms, the primary exposure
variable, assessment was made using a locally validated
version of the Patient Health Questionnaire (PHQ-9) [43,
44] at a cut off of five or more indicating probable
depression. Both the primary exposure and potential con-
founding variables were assessed at baseline, in the second
trimester and the early third trimester [30].
Potential confounding variables
Potential confounders of the association between ante-
natal depression and perinatal complications, such as
pregnancy intention, intimate partner violence, any
chronic medical condition, receipt of care, life events and
history of complications, were identified from the litera-
ture. Pregnancy intention was assessed using an item from
Ethiopian Demographic Health Survey (EDHS) that asks
whether mothers wanted to have the current pregnancy
(“wanted”) or wanted to delay (“mistimed”) or never
wanted it at all (“unwanted”) [34, 38]. Intimate partner
violence was assessed using the Women’s Abuse Screen-
ing Test (WAST) with a five item scale [45]. Its score
ranges 0-16 and a score greater than one indicates the
presence of domestic violence [45].
The number of antenatal care visits was also recorded.
The number of physician-diagnosed chronic medical
conditions, including tuberculosis, HIV, renal disease
and cardiac disease, were counted for each woman and
recorded as “none” for those without any chronic med-
ical conditions and “one or more” otherwise. Participants
were also asked if they had a history of death of a child
in the perinatal period, “history of adverse perinatal out-
comes”. The number of threatening life events was
assessed using a 12 item scale which has been adapted
and used previously in Ethiopia [46]. Alcohol use was
assessed using a four item scale, the Fast Alcohol
Screening Test (FAST) [47]. The FAST score ranges
from 0 to 16, where a score of three or more indicates
hazardous or harmful drinking [47]. Socio-demographic
and economic variables, including marital status, resi-
dence (rural/urban), monthly household income and
level of education were also assessed. Household income
was categorized into tertiles as “low”, “medium” and
“high” income categories. Marital status was categorized
as “married” or “single” since the number of unmarried,
widowed and divorced women was small.
Data analysis
Stata statistics software (version 13.1, Stata Corp, College
Station, Texas) was used for data analysis. Spontaneous
abortion and stillbirth were combined as “pregnancy loss”
as the numbers were small. Two sample proportion test
was used to explore whether baseline sample and follow-
up samples differ in respect to selected baseline variables.
Binary logistic regression was employed to compare the
odds of pregnancy loss, neonatal mortality and experience
of each of the self-reported perinatal complications for
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women with and without antenatal depressive symptoms.
As an option to summarize the results and for ease of in-
terpretation, the number of self-reported pregnancy com-
plications were counted and dichotomized into “none” for
those without any of the complications and “one or more”
for those with one or more pregnancy complications.
Similarly, the number of labour and postpartum complica-
tions was also dichotomized into “none” for those without
any of respective complications and “one or more” for
those with one or more respective complications. We
combined these complications since maternal complica-
tions are often comorbid with one another [16, 17]. The
total number of missing data for outcomes and loss to fol-
low up was 71 (5.4%) including 30 women who didn’t
deliver until end of follow up time. Thus, complete case
analysis was used as it was suggested that less than 5% lost
to follow up was with little concern [48, 49].
Results
Cohort characteristics
Out of 1311 pregnant women recruited into the study at
baseline, 1240 (94.6%) were again interviewed at the
follow-up time-point (median of eight weeks; interquar-
tile range of 6-11 weeks postpartum) (Figure 1). Women
in the complete follow-up sample were not significantly
different in their baseline characteristics from the base-
line sample. Of those followed-up at all-time points,
nearly half of them (48%) were in the second trimester
and the remaining were in the third trimester. More
than one quarter of women (28.7%) had a PHQ-9 score
of five or more indicating probable depression (20.9%
had PHQ-9 score of 5-9 and 7.8% had PHQ-9 score of
10 or more) and 6.0% of them had reported hazardous
level use of alcohol. Pregnancy was unintended in 43.8%
of women, with 36.5% of pregnancies unwanted and
7.3% mistimed. The mean score of intimate partner
violence was 2.1 (standard deviation (SD) of 2.9). The
mean parity of participants was 2.7, SD = 2.1 (Table 1).
Antenatal depressive symptoms and potential perinatal
complications
Scoring five or more on the PHQ-9 was associated with
increased odds self-reports of pregnancy complications
such as oedema [adjusted odds ratio (aOR = 2.68, 95%
CI: 1.87, 3.83)], blurred vision (aOR = 1.89 95% CI: 1.41,
2.54), severe abdominal pain (aOR = 2.29, 95% CI: 1.73,
3.04), abnormal vaginal discharge (aOR = 2.08, 95% CI:
1.44, 2.98), burning sensation at urination (aOR = 1.67,
95% CI: 1.19, 2.34) and severe headache (aOR = 1.96,
95% CI: 1.49, 2.58) (Table 2). There was a more than
two times increased odd of one or more (composite)
pregnancy complications among women with antenatal
depressive symptoms (aOR = 2.44, 95% CI: 1.84, 3.23).
Women with antenatal depressive symptoms had in-
creased odds of labour complications [severe headache
(aOR=1.84, 95% CI: 1.37, 2.46), convulsion (aOR = 1.42,
95% CI: 1.07, 1.87), haemorrhage (aOR = 1.74, 95% CI:
1.31, 2.33), unconsciousness (aOR = 1.48, 95% CI: 1.00,
2.19), fever (aOR = 1.98, 95% CI: 1.48, 2.64), premature
rupture of membranes (aOR = 1.81, 95% CI: 1.11, 2.92),
prolonged labour (aOR = 1.98, 95% CI: 1.43, 2.73) and
retained placenta (aOR = 1.57, 95% CI: 1.08, 2.30)]
(Table 2). Women with antenatal depressive symptoms
also had increased odds of one or more (composite)
labour complications (aOR = 1.84, 95% CI: 1.34, 2.53).
Fig. 1 Diagram to show participant recruitment process
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Among women with antenatal depressive symptoms,
there was increased odds of all postpartum complications
[edema (aOR=2.37, 95% CI: 1.39, 4.04), blurred vision
(aOR=1.74, 95% CI: 1.29, 2.36), severe abdominal pain
(aOR=1.61, 95% CI: 1.21, 2.15), burning sensation at urin-
ation (aOR=1.59, 95% CI: 1.16, 2.18), severe headache
(aOR=1.68, 95% CI: 1.24, 2.25), convulsion (aOR=1.69, 95%
CI: 1.24, 2.32), haemorrhage (aOR=1.60, 95% CI: 1.22,
2.17), unconsciousness (aOR=2.45, 95% CI: 1.25, 4.80) and
fever (aOR=1.87, 95% CI: 1.37, 2.54)] (Table 2). Women
with antenatal depressive symptoms also had increased
odds of composite postpartum complications (aOR=1.70,
95% CI: 1.23, 2.35) in the multivariate model (Table 2).
In the multivariate model (Table 2), neonates of
women with depressive symptoms had increased odds of
difficulty of breathing or fast breathing (aOR = 1.70, 95%
CI: 1.12, 2.58) and convulsions or spasms (aOR = 1.72,
95% CI: 1.12, 2.65) compared to women without depres-
sive symptoms according to women’s self-reported mea-
sures. But, the association of antenatal depressive
symptoms with composite neonatal complications became
marginally non-significant in the multivariate model
(OR=1.30, 95% CI: 0.98, 1.73) (Table 2). However, when
severity of antenatal depressive symptoms was considered,
the odds of each of the potential perinatal complications
(maternal and neonatal) did not consistently increase with
severity (Table 3). In the multivariate model, antenatal de-
pressive symptoms were not associated with pregnancy
loss (aOR = 1.26, 95% CI: 0.65, 2.44) or neonatal mortality
(aOR = 2.03, 95% CI: 0.73, 5.63) (Table 4).
Table 1 Characteristics of participants
Characteristics Baseline (N=1311) Followed up (N=1240) Pearson Chi2
Variables Values N (%) N (%)
PHQ-9 Status PHQ < 5 924 (70.5) 884 (71.3) 0.2024 (p = 0.653)
PHQ ≥ 5 387 (29.5) 356 (28.7)
Marital Status Married 1293 (98.6) 1225 (98.8) 0.1331 (p = 0.715)
aSingle 18 (1.4) 15 (1.2)
Residence Urban 103 (7.9) 98 (7.9) 0.0700 (p = 0.790)
Rural 1208 (92.1) 1142 (92.1)
Alcohol use Non-users 875 (64.7) 828 (66.8) 0.0134 (p= 0.993)
Mild level users 359 (27.4) 338 (27.3)
Harmful level users 77 (5.9) 74 (6.0)
Household Income High 429 (32.7) 414 (33.4) 0.1700 (p = 0.919)
Medium 423 (32.3) 392 (31.6)
Low 459 (35.0) 434 (35.0)
Mother's Education Non-literate 878 (67.0) 841 (67.8) 0.2185 (p = 0.897)
Grade 1-8 380 (29.0) 351 (28.3)
Grade 9-12 and above 53 (4.0) 48 (3.9)
Parity Nulliparous 254 (19.4) 226 (18.2) 0.5506 (p = 0.759)
Primipara 193 (14.7) 185 (14.9)
Multipara 864 (65.9) 829 (66.8)
Pregnancy intention Wanted 734 (56.0) 696 (56.1) 0.1823 (p = 0.913)
Mistimed 102 (7.8) 91 (7.3)
Unwanted 475 (36.2) 453 (36.5)
Pregnancy complications None 655 (50.1) 627 (50.6) 0.0926 (p = 0.761)
One or more 656 (49.9) 613 (49.4)
Chronic illness None 871 (66.4) 832 (66.5) 0.0014 (p= 0.971)
One or more 440 (33.6) 419 (33.5)
Perinatal outcomes Live birth – 1169 (94.3) –
Pregnancy loss – 52 (4.2)
Neonatal mortality 19 (1.5)
aSingle Marital Status= unmarried, widowed, divorced); Married = living with marital partner and married but living separate; Income was categorized into tertiles
as low, medium and high; Social support score: minimum = 3; Maximum = 14; Mean=10.68; SD=2.00; Number of ANC visits: minimum = 0; Maximum= 8; Mean =
1.524; SD=1.50
Bitew et al. BMC Psychiatry  (2017) 17:301 Page 5 of 12
Discussion
Antenatal depressive symptoms and self-reported peri-
natal complications were common in the study area.
More than half of participants reported having at least
one or more of self-reported perinatal complications. In
similar non-clinical studies, which reported patient de-
fined perinatal complications, almost 50% of the partici-
pants reported some type of illness during pregnancy
[50]. Similarly, a study of non-severe maternal morbidity
in Malawi and Pakistan reported that 50.1% and 53% of
women respectively reported having at least one preg-
nancy complications, infective or non-infective [29].
Depressive symptoms found to be associated with up-
to three times increased odds of almost all self-reported
symptoms of perinatal complications during pregnancy,
delivery and postpartum. The associations of antenatal
depressive symptoms with pregnancy loss and neonatal
mortality were non-significant. The study found
consistently strong association of antenatal depressive
symptoms with all self-reports of perinatal complications
in LMICs settings where there is lack objective evidence
about perinatal complications. The finding has future
importance in designing intervention strategies of ante-
natal depressive symptoms so as to improve the risk of
perinatal complications.
The increased odds of self-reports of perinatal compli-
cations among women with antenatal depressive
symptoms in our study supports studies in HICs where
antenatal depression was associated with a pre-
eclampsia [15, 16], wide range of other individual and
combined pregnancy complications such as gestational
hypertension, premature rupture of membranes, and
various infections (Urinary Tract Infections, cervical,
vaginal, intra-amniotic infections) [16, 17]. Our study
also supports increased association of antenatal depres-
sive symptoms with individual and combined delivery
complications (assisted delivery, non-progressive labor,
shoulder dystocia, postpartum hemorrhage, meconium,
Table 2 Impact of having antenatal depressive symptoms on each of self-reported perinatal complications
Self-Reported Perinatal
Complications
During Pregnancy During Labour Up to 7 days Postpartum Neonatal
n (%) aOR (95% CI) n (%) aOR (95% CI) n (%) aOR (95% CI) n (%) aOR (95% CI)
Edema 172 (13.8) 2.68 (1.87, 3.83) – 70 (5.6) 2.37 (1.39, 4.04) – –
Blurred vision 293 (23.6) 1.89 (1.41, 2.54) – 301(24.3) 1.74 (1.29, 2.36) – –
Severe abdominal pain 349 (28.2) 2.29 (1.73, 3.04) – 382 (30.8) 1.61(1.21, 2.15) – –
Abnormal discharge 163 (13.2) 2.08 (1.44, 2.98) – 187 (15.1) 1.42 (0.99, 2.02) – –
Burning sensation at urination 201 (16.2) 1.67 (1.19, 2.34) – 257 (20.7) 1.59 (1.16, 2.18) – –
Severe headache 398 (32.1) 1.96 (1.49, 2.58) 340 (27.4) 1.84 (1.37, 2.46) 338 (27.3) 1.68 (1.24, 2.25) – –
Convulsion – – 491 (39.6) 1.42 (1.07, 1.87) 257 (20.7) 1.69 (1.24, 2.32) – –
Haemorrhage – – 378 (30.5) 1.74 (1.31, 2.33) 420 (33.8) 1.60 (1.22, 2.17) – –
Unconsciousness – – 152 (12.3) 1.48 (1.00, 2.19) 41 (3.3) 2.45 (1.25, 4.80) – –
Fever – – 368 (29.8) 1.98 (1.48, 2.64) 274 (22.1) 1.87 (1.37, 2.54) – –
Premature Rupture of Membrane – – 92 (7.4) 1.81 (1.11, 2.92) – – –
Prolonged labour – – 264 (21.3) 1.98 (1.43, 2.73) – – –
Tear – – 92 (7.4) 1.19 (0.72, 1.99) – – –
Retained placenta (30 min) – – 66 (13.4) 1.57 (1.08, 2.30) – – –
Difficulty or Fast Breathing – – – – – – 129 (11.0) 1.70 (1.12, 2.58)
Yellow Skin/Eye Color (Jaundice) – – – – – – 45 (3.8) 1.08 (0.53, 2.19)
Poor Sucking or Feeding – – – – – – 48 (4.1) 0.76 (0.39, 1.50)
Pus, Bleeding around Umbilical
Cord
– – – – – – 162 (13.8) 1.38 (0.94, 2.01)
Skin Lesions Or Blisters – – – – – – 129 (10.1) 1.18 (0.77, 1.80)
Convulsions/Spasms/Rigidity – – – – – – 115 (9.8) 1.72 (1.12, 2.65)
Lethargy/Unconsciousness – – – – – – 35 (3.0) 1.11 (0.51, 2.39)
Red or Swollen Eyes With Pus – – – – – – 53 (4.5) 1.50 (0.80, 2.80)
One or more of any symptoms 700 (56.4) 2.44 (1.84, 3.23) 826 (66.6) 1.84 (1.34, 2.53) 804 (64.8) 1.70 (1.23, 2.35) 418 (35.6) 1.30 (0.98, 1.73)
N = total sample size; n = number of cases having perinatal complications ( % = percentage of cases having perinatal complications)
Controlled for alcohol use, residence, marital status, household income, education, intimate partner violence, life threatening events, number of ANC visits, parity,
pregnancy intention, chronic conditions, and previous experience of adverse perinatal outcomes in all models and after adjusting for presence of one or more of
any pregnancy complications symptoms and delivery complications in modelling each of labour complications and postpartum complication respectively.
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and suspected sepsis) [16], premature contraction, use of
analgesics and increased nausea during pregnancy [18].
Few existing studies in LMICs also demonstrated that
antenatal depression was associated with increased risk of
prolonged labor [19, 20, 51], assisted deliveries, labor and
delivery complications such as vaginal tear, unconscious-
ness, heavy vaginal bleeding during delivery and at post-
partum, fever, malodorous vaginal discharge and leaking
urine or faeces [51] as well as preeclampsia [20, 21].
The strong association of antenatal depressive symp-
toms with self-reports of perinatal complications may be
explained by changes in life style [52], increased dis-
ability [8, 9], malnutrition [53] and food insecurity [54],
reduced social support [55] and self-care [10–12] among
women with antenatal depressive symptoms that delay
timely healthcare seeking resulting in worsened perinatal
complications among these group of women. Thus,
depression may either worsen existing complications or
increase vulnerability of women for developing compli-
cations (infection, hypertension, unsafe abortion) by
reducing women’s self-care, social support and function-
ing. But evidence regarding the impact of depression on
perinatal complications through biochemical changes is
mixed [56].
Although we did not enquire about pre-eclampsia
specifically, the significantly higher rate of symptoms like
oedema, blurred vision and convulsions around two
weeks before birth among women with antenatal
depressive symptoms suggests an elevated risk of pre-
eclampsia, which is borne out in the literature from
other settings [15, 16, 20, 21]. The findings of the
increased odds of symptoms of fever and pain during
urination and abdominal pain also suggest the risk of in-
fection may be increased among women with antenatal
depressive symptoms [16, 57]. It can also be linked to
increased effect of depression on pelvic inflammatory
diseases reported in the general population [58].
Our finding about the increased odds of prolonged
labour among women with depressive symptoms repli-
cated the findings of cohort studies in Ghana [51],
Ethiopia [19] and China [20]. It also supports the
increased risk of shoulder dystocia and assisted delivery
reported in HICs [16]. The association between ante-
natal depressive symptoms and prolonged labor in LMIC
settings may be explained partly by reduced self-efficacy
to push during labor due to fear of childbirth in a setting
where there is increased maternal mortality. It may also
be explained by malnutrition that may disable normal
progression of labor. Increased odds of intra-partum and
postpartum haemorrhage and unconsciousness in our
study also accorded with the findings in Ghana that
reported increased loss of consciousness and heavy
vaginal bleeding at and after birth among women with
antenatal depression [51].
Our finding of strong association between antenatal
depressive symptoms and perinatal complications may
Table 4 Antenatal Depressive symptoms vs adverse perinatal outcomes
Characteristics Pregnancy loss Neonatal mortality Either pregnancy loss or
neonatal mortality
(cOR, 95% CI) (aOR, 95% CI) (cOR, 95% CI) (aOR, 95% CI) (cOR, 95% CI) (aOR, 95% CI)
Depressive Symptoms: PHQ9≥5 1.12 (0.61, 2.05) 1.26 (0.65, 2.44) 1.83 ( 0.73, 4.60) 2.03 (0.73, 5.63) 1.29 (0.77, 2.14) 1.44 (0.82, 2.53)
Residence: Rural 1.44 (0.44, 4.72) 2.25 (0.44, 11.42) omitted omitted 2.00 (0.62, 6.49) 2.84 (0.60, 13.22)
House hold Income: High 0.94 (0.49, 1.81) 0.84 (0.42, 1.70) 1.22 ( 0.41, 3.67) 1.43 (0.45, 4.56) 1.01 (0.57, 1.78) 0.97 (0.53, 1.79)
Medium 0.77 (0.38, 1.54) 0.72 (0.35, 1.47) 1.10 (0.35, 3.43) 1.20 (0.38, 3.82) 0.84 (0.46, 1.54) 0.83 (0.45, 1.54)
Low 1 1 1 1 1 1
Educational Level: Secondary + 1.51 (0.45, 5.09) 2.66 (0.46, 15.24) omitted 1.00 1.08 (0.32, 3.59) 2.21 (0.53, 1.88)
Primary Schooling 0.95 (0.51, 1.80) 1.02 (0.49, 2.11) 0.85 (0.30, 2.38) 0.99 (0.31, 3.18) 0.92 (0.54, 1.59) 1.01 (0.42, 11.40)
Non-literate 1 1 1 1 1 1
Intimate Partner violence 0.85 (0.74, 0.98) 0.85 (0.73, 0.98) 0.98 ( 0.83, 1.15) 0.99 (0.82, 1.18) 0.89 (0.80, 0.99) 0.89 (0.79, 1.00)
Threatening life events 0.84 (0.65, 1.08) 0.86 (0.65, 1.14) 0.87 ( 0.58, 1.30) 0.82 (0.53, 1.29) 0.84 (0.68, 1.05) 0.84 (0.66, 1.08)
Parity 0.98 (0.86, 1.12) 1.01 (0.85, 1.19) 1.07 ( 0.87, 1.32) 1.03 (0.80, 1.33) 1.00 (0.90, 1.13) 1.01 (0.88, 1.17)
Pregnancy Intention: Wanted 1 1 1 1 1 1
Mistimed 0.89( 0.31, 2.57) 1.00 (0.34, 2.96) 0.63 (0.08, 4.90) 0.55 (0.07, 4.41) 0.82 (0.32, 2.12) 0.86 (0.32, 2.27)
Unwanted 0.62 (0.33, 1.17) 0.61 (0.31, 1.20 0.75 ( 0.28, 2.01) 0.61 (0.22, 1.73) 0.65 (0.38, 1.12) 0.61 (0.34, 1.09)
History of adverse perinatal
outcomes
1.48 (0.82, 2.66) 1.66 (0.89, 3.11) 1.63 ( 0.64, 4.18) 1.47 (0.54, 3.98) 1.52 (0.92, 2.51) 1.61 (0.94, 2.76)
pregnancy complications 1.21 (0.69, 2.10) 1.37 (0.74, 2.54) 1.15 ( 0.46, 2.85) 1.00 (0.45, 2.23) 1.19 (0.74, 1.92) 1.28 (0.75, 2.17)
other comorbid illness 0.91 (0.53, 1.54) 0.89 (0.51, 1.55) 1.12 ( 0.52, 2.42) 1.07 (0.39, 2.90) - 0.93 (0.58, 1.48)
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also be explained by somatic symptoms associated with
depression. These somatic symptoms are highly preva-
lent among people with mild and moderate depression
group compared to people with severe depression group
(a group characterized by motor retardation than
somatization) [59]. Mild depression, compared to major
depression, is again higher among pregnant women than
non-pregnant women [60] implying higher prevalence of
somatic symptoms among these group of women which
could be presented as perinatal complications.
Our finding of an increased odds of potential neonatal
complication also accords with findings in other settings
of increased risk of both severe neonatal illness [51] and
risk of fetal distress [17] among women with antenatal
depression. But, our study didn’t support the non-
significant odds of fetal distress reported in China [20].
The non-significant finding of the association between
antenatal depressive symptoms and adverse perinatal
outcomes in our study may be due to low statistical
power. Nevertheless, a large sample size cohort study in
Ghana has also reported non-significant association of
PHQ-9 assessed antenatal depressive symptoms with
stillbirth and neonatal mortality [51]. Similarly another
study in UK [26] that distinguished current antenatal de-
pression, from pre-existing depression prior to preg-
nancy, demonstrated that current antenatal depression
was not a predictor of stillbirth. The other studies [17,
19, 20] also reported non-significant findings though
they too may have been limited by low statistical power.
Nevertheless, our study did not distinguish current ante-
natal depressive symptoms from prior-pregnancy depres-
sive symptoms. However, the current study was part of a
bigger project aimed to initiate integration of mental
healthcare in primary healthcare facility. Thus, prior to
the commencement of the study, there was no accessible
mental healthcare service in the area for women to get
medical prescriptions or other healthcare interventions
for mental health problems.
The strength of our study was it was population based
prospective design with greater chance of generalizability
to all perinatal women. Our use of a locally validated
measure of antenatal depressive symptoms increased val-
idity of exposure. However, the relatively strong associ-
ation of the antenatal depressive symptoms with potential
perinatal complications in our study may be explained by
greater levels of somatic symptoms among these women,
attrition bias and the overlap of normal symptoms of
pregnancy with depressive symptoms. However, we have
previously noted for this population that somatic symp-
toms, as a presentation of perinatal depression relates to
disability and morbidity [9]. There is consistent evidence
about the association of depression and somatisation, with
somatization being an important manifestation of depres-
sion [13]. These two disorders co-occur together and were
termed as ‘common mental disorders’ [5, 9, 13, 14, 19, 61,
62]. The association between antenatal depressive symp-
toms and self-reported perinatal complications in the
postnatal period may be due to negative symptom recall
bias among women with postnatal depressive symptoms.
However, it is important to note that about 60% of mater-
nal mortality occurs during the postpartum, indicating in-
creased complications within this period [63] that are
associated with antenatal depressive symptoms persisting
to postpartum.
With the poor quality health record system in Ethiopia
[34, 37–39], we were required to rely on self-report of
the participants to document perinatal complications.
This self-report may reflect either under or over-
reporting of complication types, severity or timing of
outcome events. But, the measures had potential to as-
sess perceived ill health of the participants, a neglected
area of healthcare despite currently promoted patient-
centred healthcare philosophy in the study area and
around the world. Data collectors would declare poten-
tial participants “untraceable” after three recruiting visits
had been unsuccessful. It is possible that these partici-
pants were ‘untraceable’ due to their being depressed
and or due to physical health problems.
Conclusion
Antenatal depressive symptoms appear to have consider-
able effect on self-reported perinatal complications. Fur-
ther studies should look at whether early detection and
treatment of antenatal depressive symptoms would re-
duce the risk of perinatal complications.
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